Cipla Gets DCGI Nod To Import Moderna’s COVID Vaccine For Emergency Use In India
New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted ...
- Latest
- Trending
New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted ...
Cipla Limited has entered into a partnership with Premier Medical Corporation Private Limited for the commercialisation of the rapid antigen ...
New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against ...
Bengaluru: Indian drugmaker Cipla, has priced its generic version of Remdesivir, Cipremi at Rs 4,000 ($53.34) per 100 mg vial, ...
New Delhi: Amid rising cases of coronavirus, there are reports about supply shortage and selling of two life-saving drugs — ...
Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold ...
© 2024 Frontmedia